
Gabriela Cordero - When the Roadmap Came with Inventory
Gabriela Cordero is Director of Product Management at MedWatch Technologies, where she leads product strategy and commercialization for the company’s biosensing wearable platform.
She has spent more than 10 years building products across digital health, fitness, and wellness, including work on Nix Biosensors’ hydration wearable at SweatWorks and hardware/software integrations for group training at Life Fitness. Her work sits in the messy middle of product, data, hardware, partnerships, and real-world use.
Follow and Subscribe
Some product bets fail because the idea was wrong.
Some get a lot messier because the world around it changed.
Gabriela Cordero joins Marco and Jonas to talk about building health and fitness products where that kind of thing happens. One launch had the product, the inventory, and the plan. Then COVID hit, gyms closed, and the team had to work through what happens when a hardware product is ready, but there’s nowhere for the inventory to go.
That leads into a bigger conversation about hardware and software product work. Software can move fast, at least in theory. Hardware asks for more commitment. Sensors, manufacturing, inventory, timelines, and physical design all make the product calls feel a little less reversible.
Gabriela also talks about what she’s building now at MedWatch Technologies: a needle-free glucose wearable. She gets into the process behind bringing that kind of product to market, from the science behind the signal and the hardware constraints to validation, FDA positioning, and how glucose data becomes useful beyond traditional disease management.
Gabriela breaks down:
- What happens when a hardware product launches into conditions no one planned for
- Why hardware product decisions are harder to unwind than software decisions
- How customer research and market feedback shape product roadmaps
- Why AI changes parts of software development faster than hardware development
- Why product teams need to separate a good idea from the right feature to build now
- How acquisition dynamics can create product conflict inside larger companies
- What she learned from helping bring Nix Biosensors’ hydration wearable to market
- Why form factor matters more as wearables move into more personal health use cases
Follow Gabriela
LinkedIn: https://www.linkedin.com/in/gabriela-cordero1
Follow Marco Benitez and Jonas
Marco: https://www.linkedin.com/in/marcobzg/
Jonas: https://www.linkedin.com/in/jonas-ducker-37460bb3/
Get in touch with This Feature Will Save Us Podcast
LinkedIn: https://www.linkedin.com/showcase/this-feature-will-save-us
Website: https://thisfeaturewillsaveus.com
Email: jonas@tryrook.io
Powered by
ROOK: https://www.tryrook.io/
Timestamps
1:50 - Hardware, software, and why Gabriela likes B2B2C
5:40 - The highs and lows of building hardware products
6:20 - Launching fitness equipment during COVID
11:10 - Hardware vs software product cycles
12:50 - Where AI helps, and where hardware is still very hands-on
14:20 - Sensor miniaturization and the future of wearable form factors
15:20 - What MedWatch Technologies is building
17:10 - The needle-free wearable Gabriela’s team is developing
20:40 - Chasing the founder vision when the product has never existed before
21:45 - Clinical trials, scientific validation, and building from data
24:45 - Managing product, commercial, marketing, and brand work in an early-stage startup
26:30 - How Gabriela thinks about roadmap tradeoffs
27:20 - What happens when leadership wants a feature the market may not need
30:45 - The product Gabriela is proud of helping bring to market
36:10 - The feature that will save us: glucose visibility
37:00 - Connecting glucose data to food, movement, sleep, and behavior
38:20 - Where to find Gabriela and MedWatch Technologies
Transcript
Marco Benitez (00:00)
Gabriela Cordero, it's unplacer start contigo. We can do a mix between English and Spanish, and I'm so happy to do so. because it's the first time I will feel comfortable with talking between English and Spanish. So really great to have you here. we would love to start with you with a fire questions.
Gabriela (00:20)
All right, let's do it.
Marco Benitez (00:21)
Because that will
help us to be, you know, we can shake a little bit and start, you know, asking tough questions product and features So let's start. Do you want to start, Jonas?
Jonas Dücker (00:34)
I can start. We're gonna start a bit more on the personal side. cardio or strength training?
Gabriela (00:40)
⁓ ask me a year ago, it would have been cardio today. is strength all the way.
Jonas Dücker (00:47)
Then I have to do a follow up question, is it something like Hyrux or CrossFit?
Marco Benitez (00:50)
pretty.
Gabriela (00:53)
Neither.
Jonas Dücker (00:54)
Core strengths, weight training.
Gabriela (00:56)
Full strength, I've become a gym bro.
Jonas Dücker (00:59)
Awesome.
Marco Benitez (01:02)
That's cool.
Mexico City or Chicago?
Gabriela (01:03)
you
Ooh, both are different. And I, you guys know, I lived in Chicago for six years and now I've been in Mexico city for four officially a Mexican resident. So thank you. Thank you. You know, I think I would say Mexico city, because I get to live a little bit of both worlds in terms of being able to, relate to my.
Marco Benitez (01:16)
Congratulations, that's cool.
Gabriela (01:32)
Hispanic background and speaking Spanish every day. It's obviously improved tremendously since the day I first got here. the culture is wonderful. and the weather, you can't beat the weather in Mexico City. It's awesome.
Marco Benitez (01:46)
It is.
Jonas Dücker (01:47)
Hardware product or software product?
Gabriela (01:50)
me, it's both, right? And hardware is what enables product software obviously include the interpretation layer to make your product really successful all around.
Marco Benitez (02:01)
B to B, B to C, B to B to C Which one do you prefer?
Gabriela (02:07)
So B to B to because I think it really helps.
enter the market with established companies that already have user bases that trust them and their product. And so for us, we'll get into what I've been doing for the last year or so, but you know, where we're going B2B2C allows us to really connect with our end users to the customers to be partnering with.
Jonas Dücker (02:34)
Awesome. Switching back to personal. The hardest physical challenge or competition you've ever trained for or you ever did.
Gabriela (02:44)
marathon training. I've run four marathons and it's never the same. Each one is very different. And training in Mexico City at high altitude learning curve for me. Because I had different beasts altogether. You know it well, Jonas. You run a marathon here in the city. Kudos to you, because I still wouldn't attempt to do that.
Jonas Dücker (02:55)
Different beast. Yeah.
First one here actually in Mexico City. Not a good idea to start in Mexico City.
Gabriela (03:09)
Yeah.
Marco Benitez (03:10)
It is not. one app outside healthcare you admire.
Gabriela (03:16)
I have to say Strava. Strava, think really understood the gap in the market, right? So I have always worn a Garmin watch for running and obviously Garmin owns watches, bike computers, data, but they really lost when it came down to community. And I think Strava saw the opportunity that fitness is social and emotional.
then that data piece just enabled them to really build a business ⁓ and a community around rewarding people for achievements, different milestones. So I think Strava has really done a great job.
Marco Benitez (03:55)
Do you saw the last news from Strava that now you can integrate with Cloth? That feature it's really interesting. Any thoughts?
Gabriela (04:05)
It's really interesting.
no. So I've, I've pivoted away from using Strava because I haven't been running in the last year. So I'm not too up to date with that integration, unfortunately, but it is interesting. don't.
My assumption is that people want more.
And I don't want to say data, but they want more visibility into the trends week over week versus just, you trained one hour over, you know, the last four weeks or you've increased X, Y, Z. think people want more personalization in real time as it relates to the historical trends that some of these applications are showing them.
Jonas Dücker (04:50)
what I found interesting as well is like it it might lead into you can take your Strava data and now you can pair it with your Google Calendar data, etc. So you you might even get more personalized recommendations on workout windows, you know, like any type of information that correlates more to your work life kind of setting rather than just the the actual fitness information, content, social aspect of of Strava. So
Maybe we can switch gears a little bit and dive a bit more into into the conversation. as you know, the podcast is all about the highs and the lows in building products and great products. So as much as you're willing to share, we're we're keen to hear the good and the bad, especially the bad actually. so maybe we can just dive right in, first of all, you giving us a little snapshot of like the highs and lows in your product career. comes to mind from building great products to
Marco Benitez (05:19)
Yeah.
Gabriela (05:20)
All
right.
Hahaha!
Jonas Dücker (05:44)
Massive fails and you don't have to you don't have to to drop names on the fails ⁓ if you don't feel comfortable. But yeah, give us a snap.
Marco Benitez (05:50)
But please, if you can share with us.
No one is going to hear about it. No no worries.
Gabriela (05:56)
I know, I know. ⁓ gosh. You know, there's been a lot of highs and lows and I think it's one of the, one of the things we talked about earlier was around hardware development, right? And so that development cycle is very different to software.
follows a more waterfall approach, just given the lead times in tooling, any sort of manufacturing components, testing, especially.
as it relates to fitness equipment, which is where I spent a good chunk of my career leading new product a global fitness company. so, you know, one of the probably biggest challenges was how do you unforeseen
And for us at the time, it was unfortunately global pandemic. And so how do you launch a product in the middle of
80 % of the world having their gyms being shut down and you're sitting on inventory that you can't ship because there's no one there to receive it. So I would say that was probably one of our biggest challenges was, you know, developing a product that took into account customer and the end user into perspective. But really it came down to not being able to ship because
we weren't able to. so early adoption for that product became a little challenging because we were sitting on inventory and some of the features that made this product really unique was that it used a generator to recharge the console. And if you have products sitting in a warehouse for months not being used, then once they were delivered to the gyms, well, people had to get on it to start charging them so they were actually functioning.
So very challenging to launch a product during COVID that you thought was really going to disrupt a specific category, but unfortunately fell a little short because of global conditions.
Marco Benitez (07:55)
that's a really interesting one. And you don't have to say the name, I can imagine which which was, but how do you handle it as a product, as a team, with your team? Is i you have this chunk of a lot of you know equipments in the inventory over there? do you handle that part?
Gabriela (07:57)
Yeah.
Yeah, I mean, you ship to the customers that are able to receive it. So the U.S. obviously was relatively open for the most part. ⁓ But Europe and Asia, that was delayed for a while.
Marco Benitez (08:30)
That's crazy. That's crazy. That happened.
Gabriela (08:31)
Mm-hmm.
Mm-hmm.
Jonas Dücker (08:34)
Is that something then like that's really on the product team to iterate on? Like is is that a product decision, the call of okay, what do we do now is the inventory, how much is product has product been really involved there, or has this been more of a company strategic direction then that you were like, Okay, let's focus all in on US market. We net we need to get the inventory out because we can't sit on I mean that's also capital that's kind of locked in, right? Like from a business perspective, which is not moving, which is not generating. So like how how much
Yeah.
Gabriela (09:07)
Well, it's, it's involved to, to an extent because obviously you have capital investment from the business on a new product launch, right? that particular product, went slightly over budget, but nothing too,
too, too significant. but the delay is, as we were mentioning earlier in getting product over from
we were manufacturing this with a partner over in Taiwan, those containers, that shipment took longer than expected. So unfortunately, the business had to make a decision in, how do we mitigate this and where can we actually sell the product in order to minimize significant loss, right? And slower ROI on a very favorable project that again, was gonna be a slam dunk in the category.
Marco Benitez (10:01)
That's interesting. And what happened after? So let's say you move forward, you start to bring those products to the US. How was the adoption? Because you create the product with the whole team and then what happened? was a very good adoption, it wasn't. What happened over there? Because what w was COVID, right?
Gabriela (10:21)
Yeah, I mean, I had several products in gyms in downtown Chicago that I could actually walk to
engagement. Obviously we did a lot of product testing, but ultimately it was an executive I wasn't truly a part of once more product was in the market. I had already left Life Fitness at the time.
Jonas Dücker (10:45)
Challenging, challenging, challenging. I mean that that's almost like give leading me to a question around like product management in a hardware company setting and a software setting. In your background, you've done both, obviously. You've you've you've seen both worlds. what's your feeling there when it comes to especially this kind of market adoption, go to market side of things, when you compare a bit your experience in hardware and software, is that very different from how product interacts with go-to-market and marketing teams, sales teams?
Gabriela (10:46)
very.
Jonas Dücker (11:15)
Or is that pretty similar for both worlds, hardware and software from your experience?
Gabriela (11:20)
No, I would
say it's pretty similar. process, to be honest, I don't think there's much change. You know, a lot of what I've done throughout my career has always been driven by customer and market research. right? I think there's this notion that we're not just going to launch another product to create another solution in the market. And ultimately it just creates another problem. I think it's really identifying how you can
improve customer pain points and deliver a solution that's going to be a value to them. The difference is that obviously with software you're able to iterate a lot faster than you do with hardware. And again, it's really around ⁓ long lead item times, but with software you have the ability to really iterate fast. So from that aspect, I really love software development a little bit more, ⁓ but really what I...
I've always been at the intersection of both. I've never really focused on one versus the other.
Marco Benitez (12:19)
I want to ask you more things about hardware. I love hardware. Because it it's really interesting. It's like ⁓ do you see any difference between before and now with the new tools that we have with AI and modeling and everything? Because my thing is before was a little bit more difficult because again you have to think in the future, right? And you cannot iterate. That's the big problem.
Gabriela (12:23)
Okay.
Marco Benitez (12:47)
And now you have these AI tools that you can at least ask questions and try to different hypotheses about what's going to happen and then the features and whatever. But do you see any difference between what happened before and now? And if so, what are those differences
Gabriela (12:57)
Mm-hmm.
For my team, I'm not sure that AI is leveraged very highly on the hardware development side, because if we think about the designs of board for electrical components, that's very specific. But yeah, I mean, I have a 20 person AI team on the software side
the experts in being able to leverage AI into the models that we're building. But on the hardware side, I would say that it's still very hands-on and a little bit more traditional in the sense of how that product is being developed.
Marco Benitez (13:42)
That's interesting. Because my thoughts were like maybe now that you have more tools you can do something than before. because I think it's really difficult how you are bringing all these new things and think on future. It's like today I'm not sure if you saw also the news with Tesla. Tesla what's going on right now is the the full self driving
You cannot use it with the previous hardware, the hardware three, and hardware four is the only one who is going to have that service. And it's gonna be coming something really interesting. It's a lot of discussions outside. Also, it's like a lot of people making demandas. How do you say demandas demanding? Yeah, I don't know in English, suing, sorry. They are suing because of that. And I mean
Gabriela (14:26)
suing.
Marco Benitez (14:32)
has a lot of repercussions if you don't take the good decisions on the fr at the very beginning, right?
Gabriela (14:36)
Of
yeah, absolutely, absolutely. I think for us on the hardware side, it's really more on. ⁓
The advancement in technology and being able to miniaturize sensors, that is really where the focus is on the hardware side, especially for our business. Not so much on the AI side relative to that, but the other day I think I saw an implantable chip in a tooth. we're talking, that's how small sensors have been miniaturized today where
Marco Benitez (15:11)
Right.
Gabriela (15:11)
You know,
you're seeing it not just in our world in wearables or in tech, you're actually seeing it in dentistry, right? So you're seeing this adoption of miniaturization of sensors across a vast majority of industries that are really, it's really remarkable.
Jonas Dücker (15:35)
Which is actually great point to lead a bit into like what you're doing today, the company you're you're with. correct me if I'm mistaken, but director of product management, Matwatch Technologies, and you're working on a needle-free glucose monitor. So, which is actually interesting with the question Marco just did previously, right? Hardware, software is AI changing a lot on the hardware side as well. We all know on the software side, obviously, AI has massively helped with efficiencies around coding and developing of
software quicker iterations, et cetera. But is this helpful for what you guys are doing? And maybe you can just give us a little bit more of an a context as well, an intro to what the company's up to, what what what you're working on in particular, ⁓ that would be awesome.
Gabriela (16:18)
Yeah, I would
love to. So have either of you worn a CGM before?
Jonas Dücker (16:24)
Yep. Think both of us.
Gabriela (16:25)
Okay.
Marco Benitez (16:25)
Yeah,
of course.
Gabriela (16:26)
Okay. So then you've experienced how powerful it is to understand how glucose has an effect with your body. Right. And then for those out there listening, if you've never worn one, and this is, ⁓ this is exciting because, ⁓ it's really what the opportunity that we have. So today continuous glucose data is really inaccessible.
Jonas Dücker (16:43)
This is an invitation.
Gabriela (16:54)
outside of disease management, right? Because it still requires a needle. And at MedWatch, we believe that glucose visibility should be accessible to a broader population. And so we're developing a needle-free and it is a rechargeable battery lasts five to seven days, be worn as a patch or an armband.
It's water resistant and really the idea is to be able to provide people visibility, right? So if we think about the...
problem that exists today, right? Metabolic dysfunction happens And for most people, that progression happens years before they're ever diagnosed. you know, eight in 10 adults live with metabolic dysfunction. And the problem is that solutions available today weren't made for them, there's a barrier to adoption with a medical device.
a barrier to adoption of the invasiveness of it, because it still requires a needle. And so we really want to make glucose and metabolic visibility accessible to the proactive health user.
Jonas Dücker (18:08)
So is that thought as a medical device or are we talking wellness category or where where are we standing on on that kind of perimeter?
Gabriela (18:18)
that's so exciting.
So, you know, the market looks very different to what it did five years ago. Right. And so if we think about a handful of forces that are really allowing us
to define a category, have GLP-1s have accelerated consumer engagement with metabolic health. Right. And most of those people will go off a GLP-1 within a year.
and many of them never change how they eat.
fitness activity, really not much right outside of, taking the GLP-1. And so it really creates an opportunity for platforms like us to build a solution to help drive sustainable behavior change. The second is I think that glucose awareness is growing. both Dexcom and Abbott obviously launched over the counter continuous glucose monitors. then the recent Dexcom Oura integration is a huge shift in consumer behavior where
The consumer has expressed that they want metabolic data along with physiological data,
even if they have to wear two pieces of hardware. So that in itself is like so exciting to me because they've done some early market validation that what we want to deliver to the market is wanted. And so, you know, from a regulatory perspective,
The FDA general wellness guidelines enables us to launch as a wellness tool for proactive health while we also do clinical validation in parallel for the future.
Marco Benitez (19:53)
That's perfect. So when we can start using that?
Gabriela (19:59)
So, so soon, I hope, so soon.
Marco Benitez (20:03)
Come on, we need to know the f the the dates, Gabriella. Come on, Gabby.
Gabriela (20:06)
We have
a limited launch planned for of next year.
Marco Benitez (20:13)
next year. Okay. We are going to be the first ones. ⁓ we are and you are you need to come again and definitely we can show to everyone to to see the the the the CGM.
Gabriela (20:15)
Absolutely, you guys will get.
I
Absolutely.
Marco Benitez (20:26)
That's impressive. That's impressive. It's it's crazy. It's really cool that everyone can use these these tools and start measuring. So that's great. That's great.
Jonas Dücker (20:37)
on that note, like I wanna I wanna try to get an angle from you like more from the product perspective. So it's obviously something new. I I don't know. I think there's no needle-free glucose monitor out there yet existing. So we're really talking about something that's completely new, it's it's innovative and it's it's figuring out how to get there, right? Like it's probably you guys sat down and you you thought it's it's possible, it has to be possible, but then obviously the the pressure is always on product, okay.
The crazy founder, the crazy CEO vision, and now the product team is like, how do I deliver? Like how can I get it done? Like so, like what what's been the approach here? have you been working with academia as well, research institution? Like how do you get to something where you feel like okay, we're we're actually getting something that's close to a medical clinical grade that which is obviously needed for for such a product. So like yeah, help us maybe even in terms of methodologies and everything that comes to mind from a product.
angle help us understand how do you chase that founder CEO vision as a product team behind vision.
Gabriela (21:43)
Yeah.
I mean, you said it right. There's no needle free solution in the market today. This category has had a ton of capital invested in it for decades. you know, I think a lot of companies have solved for different pieces of the puzzle. What makes us unique is that we have really solved for accuracy, miniaturization and form factor.
And so, yeah, we have just completed our fourth clinical trial. You know, we have a team of scientists, our chief science officer 30 years experience in glucose research. He's a chair at the University So, you know, we have a very extensive team.
scientific and medical team really working with us to make sure that, you know, everything that we do is grounded in data and science. and then from, ⁓ from a product perspective, you know, think earlier I mentioned, have two patents allowed five pending and they're really in two categories. one is in our multi-sensor, approach. So.
Part of where other companies have been unsuccessful is they've been focused in single technology solutions like optics, photonics, and we are combining light, RF, and other electromagnetic signals to produce that glucose signal. And then the other category patents are in
are in our AI to be able to correlate that glucose signal to actual data to the end user.
Jonas Dücker (23:24)
you have to calibrate against an actual glucose monitor medical grade? Or is it something that actually you because I'm still confused here maybe between is it an actual reading or is it a proxy? Like do we just get a like a close proxy to this should be where you are from a glucose level perspective and you have to calibrate this from time to time against a medical grade device?
So that we can kind of keep it in charge and keep it like learning so that the proxy is becoming better and better, or is it an actual reading? ⁓ and I don't even know where the where the the line is drawn between actual reading and and and like a proxy, but yeah.
Gabriela (24:04)
No,
yeah, so our product will not require any calibration and all of our testing is done against the Dexcom G7. That is really the gold standard around continuous glucose monitoring. And so we're able to actually have a glucose correlation to a G7. Absolutely, yeah.
Jonas Dücker (24:24)
Awesome. Exciting.
Marco Benitez (24:25)
Yeah, that's great because normally it's what happened,
right? You have to compare with the gold standard, and then depending on that, then you have the you have the ability to start to see that you are also FDE approved or you are a medical device, which is great. I have more questions for you about your career, Gabby. because Jonas mentioned something really interesting about vision that the founder
the team and everything. ⁓ you have been again, I I said that at the very beginning. You had an impressive career working with big, big companies and also building products. And we know it's really difficult. We know that it's super difficult to build products. But how do you take all the vision that the CEO have and also the pressure from investors plus
The pressure from the CTO, the whatever, C level, and then the team, because the team, they are the realistics that say, hey, this is impossible, or maybe not impossible, but will take longer. How do you handle everything? Because you are in the middle of all these discussions. How do you move forward to take, hey, okay, this feature, we need to build this feature before this one and then the other one, you know?
Make something that makes sense.
Jonas Dücker (25:50)
Th this feature will save us. You're allowed to say it, Marco.
Gabriela (25:54)
Hahaha!
Marco Benitez (25:54)
I am allowed to say that?
⁓ thank you, Jonas.
Gabriela (25:58)
You know, it's interesting. Um, and thank you for the kind words. Um, yeah, I've worked with a lot of really incredible teams and I feel very fortunate that I've, you know, I've had the ability to work with some incredible people and learn from them. And, and in my current role, I'm actually managing all commercial, efforts. so, you you're looking at the commercial, the product, the marketing, the branding team, as you know, and.
In early stage startups, we tend to wear a lot of hats. And so for me, really what always comes down to is what does the user actually need and what's going to be able to drive
value for the business, right? That has always been at the core of any product roadmap that I've ever developed, any conversations, especially around trade-offs, because there's always trade-offs in any product development cycle. And really having those discussions with the team because
know, it's not just about launching features. If those features don't help somebody move forward along the journey. So yeah, it's, really making sure that the team is in alignment with the end user and user needs.
Marco Benitez (27:10)
What happened if the CEO or the team, the founding team is not aligned with the answers that you found in the industry or with the potential clients?
Gabriela (27:23)
You know, again, I feel really lucky because we have a really collaborative team and this team because it's comprised of, doctors with PhDs in AI in their respective fields. Everybody is really data-driven. so although there is an element of
I have an old boss that would say, know, sometimes you gotta follow your really it's everything that we do is data driven. wanna make sure all the choices that we make are grounded in facts.
Marco Benitez (27:52)
Yeah.
I I agree with you, but this is with your this new company. But what happened with the previous companies? Have you ever been in that situation where were outside asking and then the C level or someone told that hey this is not the the correct way because the correct way is my thought, my idea, my baby. And you and you found that outside that no one wants that feature. you ever been in that situation?
Gabriela (28:23)
Yeah, it's always pushing back on ideas that you have ⁓ information that is
that that warrants it won't be as successful as somebody thinks it's going to be. And, you know, I, I always try to reframe it in one of two ways. And it's not killing the idea, but it's opening up the discussion to either push out that feature for a different build.
But really focusing on having the team answer, who is this for? And again, like I said earlier, what value does it provide them if we were to release this feature in the moment? So usually those conversations tend to, to go in the direction that is, is again, just most beneficial for the not so much me. I always try to remove as much bias when I'm developing products because
Although I may be a user of the products that I have developed in the past, one sample set, right?
Marco Benitez (29:23)
You're such a good person, Gabby. Come on, I w I want one example. I want No, if if you have it, because maybe maybe you work with a really good teams, right? And that's okay. But have you ever been in that situation? but it's like at least an example of something that happens. Or a friend happened that story. I don't know.
Gabriela (29:46)
I'll share a story that happened to a friend. you know, the challenge sometimes isn't necessarily around individual features to build and to release, but it's about different business happen when there acquisitions involved, right? And so...
That has been challenging in the past couple of the larger organizations I've worked for, where do you innovate a product line that is going to cannibalize an existing product line? So in the past, that has been some of the challenges for me, I think, more so than individual feature releases, to be specific.
Jonas Dücker (30:34)
also a different challenge in itself, right? When your own products might be substitutes to previous products and then if they have that are competing basically against each other. within the same organization which is which is which is tough. Awesome. I think what we jumped a little bit like and we wanted to talk about as well is killer features.
Gabriela (30:37)
⁓
you
Jonas Dücker (30:54)
What's been the coolest stuff you've been building? Like what's the the type of features products you say like I'm super proud of? that I have been involved. Anything that that comes to mind? Uhhuh.
Gabriela (31:04)
there's so many. again, think it's ranges from hardware, software. I'd say the most exciting last product I helped launch was for a company called Nix Biosensors. So Nix was a client at a product development agency I was working at. And
hydration wearable sensor that at the time runners and cyclists real-time hydration strategies for electrolyte and fluid loss. so Nix had come to us to help redesign their entire app and do some electrical and mechanical redesign to the sensor.
funny how everything you do throughout your career almost like sets the stage for what comes next. And so,
that product is very relatable to what I'm doing today with our sensor. so there was a lot of, synergies with the team when I, when I came on board, but yeah, the ability for somebody to understand how to optimize their performance. And for me as a runner was really exciting because training at altitude in Mexico city.
I mean, I didn't realize much fluid loss I was losing and how much I actually needed to hydrate to be able ensure that I was hitting my paces after kilometer for a training session. I think overall I didn't give you a specific feature for them,
a product that most recently that's been my favorite one that I helped bring to market.
Marco Benitez (32:34)
and which feature do you think is the most useful on that product? Because I think it's everything, right? And have different like mini features and that, you know, unlock a couple of things with the with your clients.
Gabriela (32:49)
for that one, I think the ability to either select from pre-populated or being able to manually input your own because and again, at the time when the product launched, because Meredith and her team have done an awesome job in really building out their partnership strategy. And I mean, they've, I remember, you know,
my first meeting with her and the team and it was focused on endurance runners and cyclists. And now, you know, she's got professional sports teams, fire departments, because hydration is also becoming a very important biomarker for people to measure. And so it's really exciting to see that she's
developing these partnerships to be able to collect more data and more awareness on the importance managing hydration.
Marco Benitez (33:40)
That's really cool. That's really cool. That leads me to another question for you. And it's like if you have to say one health or wellness ⁓ product that you admire right now, which one could be? And which feature?
Gabriela (34:00)
We haven't launched yet. Is that an answer?
Marco Benitez (34:03)
No, that's ⁓
a that's a very good answer, Gabriela. That's a really good answer. But another one. ⁓
Gabriela (34:11)
Another one. ⁓
man. You're putting me on the spot. ⁓
You know, I've been wearing my Oura ring for four years. and I
I love the focus that they're putting into women's health as well. But I also want to say that a company that I'm really, really, really focused on ⁓ is a company called Incora Health. They haven't launched yet, but there are, I'll tie it
to Oura in a second, but Incora Health is launching wearable earrings that focuses on obviously all the physiological
data that all these wearables capture, but really focusing on
where women are at in their menstrual cycle. And I think that's huge. Right. And so from a form factor perspective, I think the reason I continue to wear Oura is because it's sleek. Right. And obviously they just launched their gen five ring, which is even smaller. but what excites me a lot about this category is that it's there's so much opportunity because each
user is going to have very different form factor needs. And so there's a lot of opportunity for companies like Incora Health specifically focused in women's health to bring their product to market. So kind of gave you a little answer, very excited about what's yet to launch in the market more so than what is available today.
Jonas Dücker (35:40)
I just searched them. And they look as you good they agree. So some like Oura. It they it it it fits nicely into the, you know, everyday type of outfit without having to wear a sports watch or or so. which is great.
Gabriela (35:53)
Thank you.
Jonas Dücker (35:56)
With that, we're gonna lead a bit into the closing of the session. And we can't let you go without the question of obviously what feature will save us. So any particular feature, any particular function product, maybe even around what you're currently building,
Gabriela (36:07)
Yeah.
Jonas Dücker (36:14)
that will save us, that will be an absolute killer. keen to hear.
Gabriela (36:20)
Uh, yeah, I'm going to go back and say it's glucose visibility. you know, it is the first indicator that there is metabolically in your body. Right. And so for me, the ability to make glucose accessible to the broader population is going to be, is going to change how we think about proactive health.
and, and really prevention, right. And, and I'm, very excited about the opportunity to bring a wearable product to the subset of the population that is interested, but the tools today weren't developed for them. And so giving them this visibility into how, you know, visibility and tied to context like
what they eat, how they move, how they slept affecting their day-to-day life and then being able to provide them with actionable insights drive those measurable outcomes I think is what's gonna save us.
Marco Benitez (37:23)
That's beautiful. Can we know the price?
Jonas Dücker (37:26)
Ha ha ha.
Gabriela (37:29)
We're still working through pricing, but it'll be comparable to current wearables in the market today.
Marco Benitez (37:37)
That means a lot because we have some of them that you only have like a monthly fee and we have the other ones that are really sell their the the Oura But we yeah, we know. that's that's the more or less the range.
Gabriela (37:50)
Yeah.
And you know, I think that the consumer today is used to that pricing model. they're used to paying a price for the hardware and then a monthly subscription in the range of, you know, six to $30 a month to be able to access that data. Yeah, we're still working through some of that definition, but it'll be in line with existing products in the market today.
Marco Benitez (38:15)
That's cool, that's cool. Well, Gabriela, it was a real pleasure. Thank you, thank you so much for being here. Gracias por estar acá. Es un placer siempre verte.
Gabriela (38:15)
Yeah.
⁓ gracias
a ustedes, the dream team.
